baber/WOPTO huggingface dataset:
Patent NZ-532929-A (NZ)
Title: Method and apparatus for applying bar code information to products during production
Inventor: LUBOW ALLEN
IPC: G06K7/00
Filed: 2002-10-25
Abstract: A method and apparatus for applying bar code information to a product on a production line. The method includes the steps of printing bar code information relation to information associated with the production run that supplements first bar code information associated with the product.
Patent NZ-535220-A (NZ)
Title: Method for treating carbonaceous materials to reduce sulphur containing impurities
Inventor: LLOYD ROBERT
IPC: C01B31/02
Filed: 2003-03-05
Abstract: Processes for reducing the amount of sulfur-containing impurities in carbonaceous materials are disclosed. One process comprises contacting the materials with an aqueous solution of hydrofluorosilicic acid in the absence of hydrogen fluoride and a strong mineral acid under conditions wherein at least some of the sulfur-containing impurities react with the hydrofluorosilicic acid to form reaction products and separating the reaction products from the carbonaceous materials. Another process comprises contacting the materials with an aqueous solution of hydrofluorosilicic acid in the absence of hydrogen fluoride and a strong mineral acid under conditions wherein at least some of the sulfur-containing impurities react with the hydrofluorosilicic acid to form reaction products, separating the reaction products and the hydrofluorosilicic acid from the carbonaceous materials and subsequently treating the carbonaceous materials with a fluorine acid solution which comprises an aqueous solution of hydrofluorosilicic acid and hydrogen fluoride. A further process comprises treating the carbonaceous materials with a fluorine acid solution which comprises an aqueous solution of hydrofluorosilicic acid and hydrogen fluoride, separating the carbonaceous materials from the aqueous solution of hydrofluorosilicic acid and hydrogen fluoride, and then contacting the carbonaceous materials with an organic solvent capable of dissolving elemental sulfur.
Patent NZ-535856-A (NZ)
Title: Memory device with applications software for releasable connection to a host computer
Inventor: JAMES BARRY EDMUND
IPC: G06F21/62
Filed: 2003-03-12
Abstract: There is disclosed a memory device that is releasably connectable to a computer, and which contains at least one applications software package and associated data. Upon connection to the computer, the applications software package runs directly from the device without being uploaded or installed on the computer. In this way, a user of the device may work on any compatible computer using his or her preferred applications software packages and data, without having to configure the computer or install any particular software or data.
Patent NZ-536158-A (NZ)
Title: Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them
Inventor: VAN DYKE MARK E
IPC: A61L15/58
Filed: 2003-04-10
Abstract: Methods for producing biocompatible heterogeneous proteinaceous networks crosslinked with a heterogeneous crosslinked agent are disclosed. The disclosure particularly relates to a method for making a keratin network crosslinked by a multi-functional crosslinking agent comprising silicone, said method comprising exposing a plurality of keratin molecules comprising reactive pendant groups to said crosslinking agent under conditions effective to form covalent interprotein crosslinks between first reactive functionalities on said crosslinking agent and first reactive pendant groups on a first group of said keratin molecules, said conditions also being effective to form covalent interprotein crosslinks between second reactive functionalities on said crosslinking agent and second reactive pendant groups on a second group of keratin molecules, wherein said crosslinking agent is silicone-based and has the general structure shown herein.
Patent NZ-538834-A (NZ)
Title: Pharmaceutical compositions for inhalation containing a new anticholinergic in conjunction with corticosteroids and betamimetics
Inventor: PAIRET MICHEL
IPC: A61K31/56
Filed: 2003-07-25
Abstract: Disclosed herein are pharmaceutical compositions that are suitable as inhalation medicaments, wherein the compositions comprise at least one anticholinesterase compound of formula (I), at least one corticosteroid and at least one betamimetic drug. These pharmaceutical compositions are suitable for use in the treatment of respiratory illnesses.
Patent NZ-540385-A (NZ)
Title: Use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicamnent for treatment of brain cancer
Inventor: ZELDIS JEROME B
IPC: A61K31/425
Filed: 2003-11-06
Abstract: Disclosed is the use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicament to treat brain cancer. The compound is to be administered in a dosage from about 0.1 mg to about 150 mg per day and can be administered with a second active ingredient selected from hematopoietic growth factor, a cytokine, and an anti-cancer agent.
Patent NZ-541222-A (NZ)
Title: Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
Inventor: RUBIN STEPHEN
IPC: A61K31/5685
Filed: 2004-02-03
Abstract: Disclosed is the use of a combination of an aromatase inhibitor such as atamestane, formestane, fadrozole, letrozole, pentrozole, anastrozole and vorozole, a progestin such as norgestrel, levonorgestrel, norethindrone, norethindrone acetate, desogestrel, norgestimate and ethynodiol diacetate, and an estrogen such as ethinyl oestradiol and mestranol, in the manufacture of a medicament for the treatment of endometriosis.
Patent NZ-547793-A (NZ)
Title: Fungicidal mixtures based on carbamate derivatives and insecticides
Inventor: BEGLIOMINI EDSON
IPC: A01N47/24
Filed: 2004-12-15
Abstract: Provided is a mixture for crop protection, comprising as active components a) a carbamate derivative of formula I, in which the substituents and the index have the following meaning: T is CH or N, n is 0, 1 or 2, R is halogen, C1-C4-Alkyl or C1-C4-haloalkyl, it being possible for the radicals R to be different when n is 2, and b) a derivative of phenylpyrazole of formula II in which R1 is C1-C4-alkyl or C1-C4-haloalkyl; in a synergistic effective amount.
Patent NZ-551292-A (NZ)
Title: 3-Amino-1-arylpropyl indoles as monoamine reuptake inhibitor
Inventor: GREENHOUSE ROBERT
IPC: C07D231/56
Filed: 2005-05-27
Abstract: Disclosed are compounds of formula (I), wherein the substituents are as defined in the specification, pharmaceutical compositions containing them and methods of using them for the preparation of medicaments for treating depression or anxiety.
Patent NZ-552063-A (NZ)
Title: Chimeric and humanised monoclonal antibodies against inteleukin- 13
Inventor: ASHMAN CLAIRE
IPC: A61P37/02
Filed: 2005-06-30
Abstract: Provided is a therapeutic antibody or antigen binding fragment thereof which specifically binds hIL-13 and modulates the interaction between hIL-13 and hIL-13R and comprises a specified sequence of CDRH3. Further provided are methods of producing the antibody and use of the antibody in the manufacture of medicaments.
Patent NZ-552280-A (NZ)
Title: Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel
Inventor: SCHEFFLER ARMIN
IPC: A61K9/00
Filed: 2005-06-21
Abstract: Disclosed is a use of at least one triterpene haying an average particle size of less than 50 micrometres as an oleogel-forming agent in an oleogel. Also disclosed are said oleogel and a method of producing said oleogel.
Patent NZ-552680-A (NZ)
Title: Process for the preparation of virus-safe biological fluids
Inventor: CHANDRA VISWAMANATHAN
IPC: A61K35/16
Filed: 2005-06-27
Abstract: Provided is an in vitro process of preparing a virus safe biological material comprising: providing biological material suspected to contain a virus; contacting said biological material with solvent detergent in an amount and under conditions sufficient for substantially inactivating the virus; and removing solvent-detergent from the biological material by treatment with a synthetic polymer, wherein the synthetic polymer is a synthetic aromatic resin provided as an organic matrix; wherein the solvent is a dialkyl or trialkylphosphate, wherein the alkyl group is a straight or branched C1-C10 alkyl group.
Patent NZ-554475-A (NZ)
Title: Methods and compositions for the treatment of hyperlipidemia
Inventor: JIANG JIAN-DONG
IPC: A61K31/4375
Filed: 2005-09-19
Abstract: Provided is the use of the berberine compound of the formula below for the manufacture of a medicament for preventing or treating hyperlipidemia in mammals. The medicament may be combined with a second cholesterol lowering agent.
Patent NZ-556233-A (NZ)
Title: Management of animals
Inventor: VERNON JAMES HAROLD
IPC: A01K29/00
Filed: 2007-12-29
Abstract: A system (10) for managing animals, includes an indicator unit (12) having a receiver (14), a transmitter and an alert means (16), and an animal transponder (20), couplable to an animal to be managed. The indicator unit is portable and/or is adapted to be borne by a user. The animal transponder is arranged, in use, to transmit an identification signal corresponding to the respective animal to the indicator unit when the animal transponder is within a range of the indicator unit and the indicator unit is arranged to transmit identification data based at least in part on the identification signal received from the animal transponder to a remote computing device (28, 48). The computing device is arranged to interrogate a database in response to receipt of the identification data and to transmit a response signal to the indicator unit dependent on data associated with the animal corresponding to the identification data, and the indicator unit is configured to perform a predetermined event dependent on the response signal.
Patent NZ-565592-A (NZ)
Title: Partial item change tracking and synchronization
Inventor: DUN ALEC C
IPC: G16H10/60
Filed: 2006-07-20
Abstract: A method of increasing sync rates between a client device and a server device is provided. The method comprises the step of receiving, at the server device, a request from the client device to synchronize one or more data items that have changed after a last synchronization between the server device and the client device. Each of the data items includes a number of modifiable properties divided into a plurality of property groups. Each of the data items represents a complete message. The method further includes, in response to the request to synchronize the one or more data items that have changed after the last synchronization, the steps of: determining, at the server device, that a first data item has changed after the last synchronization; determining, at the server device, whether the property groups of the first data item include a modified property group, where a value of a property in the modified property group has changed since after the last synchronization; and synchronizing, by the server device, the modified property group with the client device without streaming to the client device one or more unmodified property groups of the first data item, where none of the properties in the unmodified property groups have values changed after the last synchronization.
Patent NZ-567962-A (NZ)
Title: Functional nanomaterials with antibacterial and antiviral activity
Inventor: BIGNOZZI CARLO ALBERTO
IPC: B22F1/02
Filed: 2006-04-24
Abstract: Disclosed is a silver ion containing nanocrystalline compound of the formula (I) containing either colloidal silica or titanium dioxide. The substituents are as disclosed in the description. The compounds are useful for antibacterial and antiviral use. Also disclosed are a composition and a dermatological composition comprising a compound according to formula (I). Further disclosed is the use of a compound of formula (I) for the manufacture of an antibacterial or antiviral medicament or the nonmedical use of a compound of formula (I). The method of rejuvenating a nanocrystalline compound of formula (I) is also disclosed.
Patent NZ-569760-A (NZ)
Title: Endoluminal prosthesis
Inventor: VENTURELLI ANDREA
IPC: A61F2/91
Filed: 2006-02-17
Abstract: An endoluminal prosthesis (stent) 500 comprises a tubular body 502 suitable to turn from a collapsed to an expanded or partially expanded condition which develops along a longitudinal axis 504. A plurality of serpentines (506a-d, 508a-e, 510a-d), or closed meander paths develop in a substantially circumferential direction. Each serpentine comprises arm portions, or arms 511, and bend portions or bends 512, which join two subsequent arms 511. The bends facing an adjacent serpentine are circumferentially offset relative to the respective and opposite bends 512 of the contiguous serpentine, both when the prosthesis is collapsed and when the prosthesis is expanded or partially expanded. A first portion 506, 510 comprises at least two adjacent serpentines interconnected by at least one bridge 514a, and at least a pair of bends situated at the shortest longitudinal distance between the two serpentines is not connected by a bridge. A second portion 508 comprises at least two adjacent serpentines interconnected by bridges 514b equal in number to the number of pairs of bends of the two serpentines being at the shortest longitudinal distance between the two serpentines.
Patent NZ-569813-A (NZ)
Title: Solid dispersion comprising an active ingredient having a low melting point and an absorbent, and a tablet for oral administration comprising same
Inventor: WOO JONG SOO
IPC: A61K9/10
Filed: 2006-12-18
Abstract: A process for preparing a tablet for oral administration comprising: (a) heating to melt an active ingredient chosen from ibuprofen, dexibuprofen (S(+)-ibuprofen), or a mixture thereof, and adding light anhydrous silicic acid thereto to obtain a homogenous fused solid dispersion; (b) cooling, drying and pulverizing the fused solid dispersion obtained in step (a) to obtain granules; and (c) adding a release-controlling agent or a pharmaceutically acceptable excipient to the granules obtained in step (b) and compressing the resulting mixture into a tablet.
Patent NZ-576521-A (NZ)
Title: Use of Tretazicar (5-(aziridin-1-yl)-2,4-dinirobenzamide) for poioning rats
Inventor: KNOX RICHARD
IPC: A01N25/00
Filed: 2007-09-28
Abstract: Provided is a method of poisoning a rat, comprising making available to the rat an orally available formulation of Tretazicar and allowing the rat to ingest the formulation of Tretazicar, wherein the formulation of Tretazicar comprises bait. Further provided are various formulations of the bait to be used in the method.
Patent NZ-587752-A (NZ)
Title: High mass and low pressure liquid propulsion with counter-rotating impellers with reversal of drive to impellers to reverse flow direction
Inventor: DAVIES BARRY JOHN
IPC: B63H11/00
Filed: 2010-09-02
Abstract: A high mass/low flow pressure propulsion device, typically for jet boat reversing, has two counter-rotating impellers 14,15 located in a housing with water normally flowing via housing inlet 12 to housing outlet 19. The rotational drive direction for the impellers is reversed to cause water to flow from outlet to inlet. An anti-ventilation hood 35 is provided to prevent air being sucked into the outlet, and is necessary unless the outlet is fully submerged.
Patent NZ-588025-A (NZ)
Title: A process for purifying staurosporine
Inventor: HOEHN PASCALE
IPC: C07D498/22
Filed: 2005-11-03
Abstract: Disclosed herein is a process for purifying staurosporine comprising: (a) providing a suspension of staurosporine in an alcohol solvent, preferably ethanol; (b) contacting the suspension with methanesulfonic acid; (c) further contacting the solution with triethylamine; and (d) isolating the product.
Patent NZ-591182-A (NZ)
Title: Production of grafted polyethylene from renewable materials the obtained polyethylene and uses thereof
Inventor: DEVISME SAMUEL
IPC: C08F255/02
Filed: 2009-07-27
Abstract: Disclosed is a polyethylene grafted by at least one grafting monomer chosen from unsaturated carboxylic acids, unsaturated dicarboxylic acids having from 4 to 10 carbon atoms, C1-C8 alkyl esters of unsaturated carboxylic acids or glycidyl ester derivatives of unsaturated carboxylic acids, or metal salts of unsaturated carboxylic acids, characterized in that at least a portion of the carbon' atoms is of renewable origin. A process for making the grafted polymer is also disclosed. The grafted polymer is used as a coextrusion tie.
Patent NZ-593387-A (NZ)
Title: Planar antenna
Inventor: LITSCHKE OLIVER
IPC: H01Q13/02
Filed: 2008-12-18
Abstract: 593387 Disclosed is a planar antenna (10) for selectively receiving two linearly polarized electromagnetic waves. The antenna includes a plate structure (12) having an upper, a central, and a lower electrically conductive plate element (14, 16, 18), which are disposed on top of one another with an upper and a lower insulating element (20, 24) being interposed, which carry an upper and a lower conductor structure. The plate elements form receiving cells (30) disposed next to one another in the form of openings (32), into which a first decoupling probe and a second decoupling probe protrude aligned perpendicular to one another and disposed on top of one another. The first decoupling probes are electrically combined by the upper conductor structure (14) and the second decoupling probes are electrically combined by the lower conductor structure (18) in amplitude and in-phase. To provide the planar antenna (10) with higher antenna gain and good polarization decoupling, the openings (32) are formed in each case by at least two mutually centrically penetrating oval recesses.
Patent NZ-598071-A (NZ)
Title: Uses of and pharmaceutical compositions comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol compounds
Inventor: BEAUCHAMPS MARIE G
IPC: A61K31/52
Filed: 2007-10-26
Abstract: 598071 Disclosed herein is the use of a crystal form of the compound of formula (Ia) or a salt thereof, wherein the compound is 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9H-purin-2-ylamino]-cyclohexan-l-ol, for the treatment of neurodegenerative disease; a cardiovascular disease; insulin resistance; a fibrotic disease; a disorder caused, induced or exacerbated by ozone, cold or exercise; syndrome X; metabolic syndrome; acute or chronic organ transplant rejection; or for the preservation of tissue and organs in a patient in need thereof. Additionally disclosed is X-ray powder diffraction patterns, differential scanning calorimetry, thermogravimetric analysis and humidity analysis. Additionally wherein the crystal form is unsolvated.
Patent NZ-598119-A (NZ)
Title: Electromagnetic flow rate meter for conduit pipe and method for manufacturing same
Inventor: MORIKITA NOBUO
IPC: G01F1/58
Filed: 2010-07-26
Abstract: A method for manufacturing a conduit pipe and the conduit pipe for electromagnetic flow meter are disclosed. The conduit pipe (101) comprises a resin-made conduit pipe having inside a passage for conductive fluid, and a measurement section formed in the intermediate portion of the conduit pipe along the direction of the passage. The measurement section (108) has a pair of electrodes (105a, 105b) for electromotive force measurement and a pair of conductive members (111a, 111b). The pair of electrodes are arranged so as to meet nearly at right angles with the flow direction of the conductive fluid passing through the conduit pipe and each electrode includes a front end nearer to the passage and a rear end distal to the front end. Each electrode includes a front end surface exposed to the inner wall surface of the conduit pipe. The pair of conductive members is each connected, inside the wall of the conduit pipe, to a rear end side of either of the pair of electrodes for electromotive force measurement. The electrodes for electromotive force measurement are moulded integrally with the conduit pipe so as to be embedded in the wall of the conduit pipe. Either a) the rear ends of the electrodes are covered with the resin constituting the conduit pipe, a seal material is provided at the boundary between the conduit pipe and the electrodes for electromotive force measurement are embedded in the inner wall of the conduit pipe or b) recesses are formed at the periphery of the conduit pipe in a direction meeting at right angles with the direction in which the pair of electrodes for electromotive force measurement are arranged, each recess is for fixing a yoke and a stake in each recess for fixing a yoke, to engage with the hole formed in the yoke, is formed integrally with the conduit pipe.
Patent NZ-598220-A (NZ)
Title: Heterocyclic compounds and uses thereof
Inventor: REN PINGDA
IPC: A61K31/54
Filed: 2010-08-17
Abstract: 598220 Disclosed herein is a compound of formula II, wherein the variables are defined in the specification, and the use thereof in the treatment of a condition associated with phosphatidyl inositol-3 kinase (PI3 kinase), specifically wherein the treatment comprises inhibiting said kinase. Embodiments of the compound include the following: 5-(3-(pyridin-4-yl)imidazo[1,2-a]pyridin-6-yl)benzo[d]oxazol-2-amine, and 2-(4-(8-(2-aminobenzo[d]oxazol-5-yl)-3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile.
Patent NZ-598777-A (NZ)
Title: Methylpyrrolopyrimidinecarboxamides
Inventor: STADLWIESER JOSEF
IPC: A61K31/519
Filed: 2010-08-24
Abstract: Disclosed are methylpyrrolopyrimidinecarboxamide compounds of formula (I), salts thereof, and methods for their preparation. Specific examples of compounds of formula (I) include: N-(1-Acetylpiperidin-4-yl)-4-[5-(cyclopropylmethoxy)-1,3-benzodioxol-4-yl]-6-methyl-5H-pyrrolo[3,2-5d]pyrimidine-7-carboxamide, 4-[2-(Cyclopropylmethoxy)-5-fluorophenyl]-N-[(3R)-1-(methoxyacetyl)pyrrolidin-3-yl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide, N-[(3R)-1-acetylpyrrolidin-3-yl]-4-[2-(cyclopropylmethoxy)-5-methoxyphenyl]-6-methyl-5H-pyrrolo[3,2-d]pyrimidine-7-carboxamide, and 4-[2-(Cyclopropylmethoxy)-4-fluoro-5-methylphenyl]-N-{ trans-4-[(methoxyacetyl)amino]cyclohexyl} -6-methyl-5H-pyrrolo[3,2 -d]pyrimidine-7-carboxamide. Compounds of formula (I) are useful for the treatment or prophylaxis of an acute or chronic airway disease, hypertension, nephritis, liver cirrhosis, toxic liver damage, hepatitis, non-alcoholic steatohepatitis or liver fibrosis.
Patent NZ-610866-A (NZ)
Title: Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient
Inventor: ISHIKAWA KUMI
IPC: A61P11/06
Filed: 2011-12-20
Abstract: The disclosure relates to a diphenyl sulfide derivative represented by general formula (1) which is useful as a pharmaceutical product that has excellent S1P3 antagonist activity, wherein R1 represents an alkoxy group having 1-6 carbon atoms, R2 represents a propyl group or an allyl group, X represents methylene or an oxygen atom, and Z represents a halogen atom. These diphenyl sulfide derivatives are suitable for treating sepsis, respiratory disorders or diseases, cytokine storm caused by an influenza virus or RS virus infection, arteriosclerosis, blood vessel intimal thickening, solid tumors, diabetic retinopathy, rheumatoid arthritis, cardiac arrest, ischemia-reperfusion disorders, cerebral bloodvessel spasms after subarachnoid bleeding, angina pectoris or myocardial infarction caused by coronary vessel spasms, glomerulonephritis, thrombosis, lung disease caused by pulmonary edema, cardiac arrhythmia, eye disease, eye hypertension, glaucoma, glaucomatous retinopathy, optic neuropathy, or macula-lutea degeneration.